Citazione APA

Abe, M., Okada, K., Suzuki, H., Yoshida, Y., & Soma, M. (2013). T/L-type calcium channel blocker reduces the composite ranking of relative risk according to new KDIGO guidelines in patients with chronic kidney disease. BioMed Central.

Stile di citazione Chicago

Abe, Masanori, Kazuyoshi Okada, Hiroko Suzuki, Yoshinori Yoshida, e Masayoshi Soma. T/L-type Calcium Channel Blocker Reduces the Composite Ranking of Relative Risk According to New KDIGO Guidelines in Patients With Chronic Kidney Disease. BioMed Central, 2013.

Citazione MLA

Abe, Masanori, et al. T/L-type Calcium Channel Blocker Reduces the Composite Ranking of Relative Risk According to New KDIGO Guidelines in Patients With Chronic Kidney Disease. BioMed Central, 2013.

Attenzione: Queste citazioni potrebbero non essere precise al 100%.